A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease
Clinical trial NCT00645190 · COMPLETED
Trial details
- NCT number
- NCT00645190
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.